NCT00290966View on ClinicalTrials.gov

Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

610

Participants

Timeline

Start Date

October 31, 1998

Study Completion Date

May 31, 2003

Conditions
Stomach Neoplasm
Interventions
DRUG

XRP6976

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00290966 - Randomized Multicenter Study Comparing Docetaxel Plus Cisplatin and 5-FU to Cisplatin Plus 5-FU in Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter